These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 15900292)

  • 1. Traditional aqueous kava extracts inhibit cytochrome P450 1A2 in humans: Protective effect against environmental carcinogens?
    Russmann S; Lauterburg BH; Barguil Y; Choblet E; Cabalion P; Rentsch K; Wenk M
    Clin Pharmacol Ther; 2005 May; 77(5):453-4. PubMed ID: 15900292
    [No Abstract]   [Full Text] [Related]  

  • 2. Development of an on-line high performance liquid chromatography detection system for human cytochrome P450 1A2 inhibitors in extracts of natural products.
    Jeurissen SM; Claassen FW; Havlik J; Bouwmans EE; Cnubben NH; Sudhölter EJ; Rietjens IM; van Beek TA
    J Chromatogr A; 2007 Feb; 1141(1):81-9. PubMed ID: 17184784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Composition and biological activity of traditional and commercial kava extracts.
    Côté CS; Kor C; Cohen J; Auclair K
    Biochem Biophys Res Commun; 2004 Sep; 322(1):147-52. PubMed ID: 15313185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and disposition of the kavalactone kawain: interaction with kava extract and kavalactones in vivo and in vitro.
    Mathews JM; Etheridge AS; Valentine JL; Black SR; Coleman DP; Patel P; So J; Burka LT
    Drug Metab Dispos; 2005 Oct; 33(10):1555-63. PubMed ID: 16033948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apiaceous vegetable constituents inhibit human cytochrome P-450 1A2 (hCYP1A2) activity and hCYP1A2-mediated mutagenicity of aflatoxin B1.
    Peterson S; Lampe JW; Bammler TK; Gross-Steinmeyer K; Eaton DL
    Food Chem Toxicol; 2006 Sep; 44(9):1474-84. PubMed ID: 16762476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Advance in cytochrome P450 1A2].
    Xiao P; Zhou HH
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 May; 33(5):456-60. PubMed ID: 18544853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of berberine on hepatocyte proliferation, inducible nitric oxide synthase expression, cytochrome P450 2E1 and 1A2 activities in diethylnitrosamine- and phenobarbital-treated rats.
    Zhao X; Zhang JJ; Wang X; Bu XY; Lou YQ; Zhang GL
    Biomed Pharmacother; 2008 Nov; 62(9):567-72. PubMed ID: 17418998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysophosphatidylserine-induced functional switch of human cytochrome P450 1A2 and 2E1 from monooxygenase to phospholipase D.
    Cho EY; Yun CH; Chae HZ; Chae HJ; Ahn T
    Biochem Biophys Res Commun; 2008 Nov; 376(3):584-9. PubMed ID: 18801337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Traditional kava beverage consumption and liver function tests in a predominantly Tongan population in Hawaii.
    Brown AC; Onopa J; Holck P; Kaufusi P; Kabasawa D; Craig WJ; Dragull K; Levine AM; Baker JD
    Clin Toxicol (Phila); 2007; 45(5):549-56. PubMed ID: 17503265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. St. John's wort and Kava in treating major depressive disorder with comorbid anxiety: a randomised double-blind placebo-controlled pilot trial.
    Sarris J; Kavanagh DJ; Deed G; Bone KM
    Hum Psychopharmacol; 2009 Jan; 24(1):41-8. PubMed ID: 19090505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High dose of commercial products of kava (Piper methysticum) markedly enhanced hepatic cytochrome P450 1A1 mRNA expression with liver enlargement in rats.
    Yamazaki Y; Hashida H; Arita A; Hamaguchi K; Shimura F
    Food Chem Toxicol; 2008 Dec; 46(12):3732-8. PubMed ID: 18930106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracts and kavalactones of Piper methysticum G. Forst (kava-kava) inhibit P-glycoprotein in vitro.
    Weiss J; Sauer A; Frank A; Unger M
    Drug Metab Dispos; 2005 Nov; 33(11):1580-3. PubMed ID: 16051732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of caffeine on the expression of cytochrome P450 1A2, adenosine A2A receptor and dopamine transporter in control and 1-methyl 4-phenyl 1, 2, 3, 6-tetrahydropyridine treated mouse striatum.
    Singh S; Singh K; Gupta SP; Patel DK; Singh VK; Singh RK; Singh MP
    Brain Res; 2009 Aug; 1283():115-26. PubMed ID: 19520064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocellular toxicity of kava leaf and root extracts.
    Lüde S; Török M; Dieterle S; Jäggi R; Büter KB; Krähenbühl S
    Phytomedicine; 2008 Jan; 15(1-2):120-31. PubMed ID: 18055189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A rapid computational filter for cytochrome P450 1A2 inhibition potential of compound libraries.
    Chohan KK; Paine SW; Mistry J; Barton P; Davis AM
    J Med Chem; 2005 Aug; 48(16):5154-61. PubMed ID: 16078835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of ketoconazole on the activity of CYP4503A4 and CYP450 1A2 of hepatic microsomes in healthy adults].
    Yang GZ; Yuan Y; Zhou QX; Yang JQ; Liu YJ
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(9):1634-5, 1639. PubMed ID: 18819885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver dysfunction markedly decreases the inhibition of cytochrome P450 1A2-mediated theophylline metabolism by fluvoxamine.
    Orlando R; Padrini R; Perazzi M; De Martin S; Piccoli P; Palatini P
    Clin Pharmacol Ther; 2006 May; 79(5):489-99. PubMed ID: 16678550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetic deuterium isotope effects for 7-alkoxycoumarin O-dealkylation reactions catalyzed by human cytochromes P450 and in liver microsomes. Rate-limiting C-H bond breaking in cytochrome P450 1A2 substrate oxidation.
    Kim KH; Isin EM; Yun CH; Kim DH; Guengerich FP
    FEBS J; 2006 May; 273(10):2223-31. PubMed ID: 16649998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of nonlamellar-prone lipids in the stability increase of human cytochrome P450 1A2 in reconstituted membranes.
    Ahn T; Yun CH; Oh DB
    Biochemistry; 2005 Jun; 44(25):9188-96. PubMed ID: 15966743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral contraceptives containing ethinyl estradiol and gestodene markedly increase plasma concentrations and effects of tizanidine by inhibiting cytochrome P450 1A2.
    Granfors MT; Backman JT; Laitila J; Neuvonen PJ
    Clin Pharmacol Ther; 2005 Oct; 78(4):400-11. PubMed ID: 16198659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.